AAPL335.06-1.94 (-0.58%) ▼|ABBV264.72+0.70 (+0.27%) ▲|ABT102.81+0.58 (+0.57%) ▲|ACN184.56-5.74 (-3.01%) ▼|ADBE249.42-3.26 (-1.29%) ▼|AMAT435.10+17.70 (+4.24%) ▲|AMD543.83-1.26 (-0.23%) ▼|AMGN382.70+2.92 (+0.77%) ▲|AMT175.20-0.38 (-0.22%) ▼|AMZN253.00+1.81 (+0.72%) ▲|AVGO355.43+8.13 (+2.34%) ▲|AXP309.96-1.21 (-0.39%) ▼|BA195.73-1.27 (-0.64%) ▼|BAC57.86-0.33 (-0.56%) ▼|BKNG169.12-1.40 (-0.82%) ▼|BLK1,051.38-2.58 (-0.25%) ▼|BMY62.69-0.15 (-0.24%) ▼|BNY152.26-0.76 (-0.50%) ▼|BRK-B507.55-1.65 (-0.32%) ▼|C132.20-0.50 (-0.38%) ▼|CAT800.90+2.33 (+0.29%) ▲|CL87.23-0.50 (-0.57%) ▼|CMCSA22.82-0.10 (-0.41%) ▼|COF201.54-0.50 (-0.25%) ▼|COP132.47-0.72 (-0.54%) ▼|COST894.45+0.52 (+0.06%) ▲|CRM240.74-2.11 (-0.87%) ▼|CSCO108.54-1.70 (-1.54%) ▼|CVS88.24-2.03 (-2.25%) ▼|CVX210.78-0.79 (-0.37%) ▼|DE682.13-3.51 (-0.51%) ▼|DHR211.00-1.50 (-0.71%) ▼|DIS103.30-2.06 (-1.95%) ▼|DUK117.30-1.24 (-1.05%) ▼|EMR148.62+1.22 (+0.83%) ▲|FDX303.30-2.58 (-0.84%) ▼|GD350.17-5.78 (-1.62%) ▼|GE311.75-1.72 (-0.55%) ▼|GEV929.71+4.78 (+0.52%) ▲|GILD150.25-0.65 (-0.43%) ▼|GM82.23-4.39 (-5.07%) ▼|GOOG345.96+2.28 (+0.66%) ▲|GOOGL349.95+2.62 (+0.75%) ▲|GS942.40-9.07 (-0.95%) ▼|HD300.88-1.63 (-0.54%) ▼|HON204.94-1.56 (-0.75%) ▼|IBM231.23-6.53 (-2.74%) ▼|INTC106.85-1.95 (-1.79%) ▼|INTU306.38-6.75 (-2.16%) ▼|ISRG393.48+9.94 (+2.59%) ▲|JNJ269.20-1.02 (-0.38%) ▼|JPM346.75-2.56 (-0.73%) ▼|KO87.90-0.16 (-0.19%) ▼|LIN457.91-0.57 (-0.12%) ▼|LLY1,146.04-6.40 (-0.56%) ▼|LMT527.63-10.46 (-1.94%) ▼|LOW193.08-1.11 (-0.57%) ▼|LRCX283.55+14.24 (+5.29%) ▲|MA566.52+0.79 (+0.14%) ▲|MCD250.02+1.54 (+0.62%) ▲|MDLZ60.95-1.09 (-1.76%) ▼|MDT92.67-0.11 (-0.11%) ▼|META672.85-9.47 (-1.39%) ▼|MMM164.38-0.33 (-0.20%) ▼|MO69.76+0.06 (+0.08%) ▲|MRK146.31-0.84 (-0.57%) ▼|MS202.25-1.27 (-0.62%) ▼|MSFT494.23-3.52 (-0.71%) ▼|MU990.10+12.60 (+1.29%) ▲|NEE80.54-0.74 (-0.91%) ▼|NFLX71.73-3.58 (-4.75%) ▼|NKE36.01-0.35 (-0.96%) ▼|NOW136.81-1.66 (-1.20%) ▼|NVDA219.68+0.34 (+0.16%) ▲|ORCL145.71-4.88 (-3.24%) ▼|PEP130.11-3.55 (-2.66%) ▼|PFE27.47-0.17 (-0.62%) ▼|PG146.09-1.47 (-0.99%) ▼|PLTR175.81-0.44 (-0.25%) ▼|PM190.39-0.09 (-0.05%) ▼|QCOM179.38-9.33 (-4.94%) ▼|RTX191.45-2.09 (-1.08%) ▼|SBUX95.91-0.76 (-0.79%) ▼|SCHW104.82+0.19 (+0.18%) ▲|SO85.63-1.13 (-1.30%) ▼|SPG204.29-0.18 (-0.09%) ▼|T25.52+0.13 (+0.51%) ▲|TMO652.52-5.81 (-0.88%) ▼|TMUS166.70+0.25 (+0.15%) ▲|TSLA362.20-4.01 (-1.09%) ▼|TXN263.77+5.63 (+2.18%) ▲|UBER70.28-0.59 (-0.83%) ▼|UNH373.91-1.31 (-0.35%) ▼|UNP278.87-3.61 (-1.28%) ▼|UPS99.09-1.08 (-1.08%) ▼|USB59.80-0.45 (-0.75%) ▼|V369.45-0.48 (-0.13%) ▼|VZ47.98-0.35 (-0.72%) ▼|WFC86.06-0.83 (-0.96%) ▼|WMT107.26+0.47 (+0.44%) ▲|XOM162.89-0.38 (-0.23%) ▼|AAPL335.06-1.94 (-0.58%) ▼|ABBV264.72+0.70 (+0.27%) ▲|ABT102.81+0.58 (+0.57%) ▲|ACN184.56-5.74 (-3.01%) ▼|ADBE249.42-3.26 (-1.29%) ▼|AMAT435.10+17.70 (+4.24%) ▲|AMD543.83-1.26 (-0.23%) ▼|AMGN382.70+2.92 (+0.77%) ▲|AMT175.20-0.38 (-0.22%) ▼|AMZN253.00+1.81 (+0.72%) ▲|AVGO355.43+8.13 (+2.34%) ▲|AXP309.96-1.21 (-0.39%) ▼|BA195.73-1.27 (-0.64%) ▼|BAC57.86-0.33 (-0.56%) ▼|BKNG169.12-1.40 (-0.82%) ▼|BLK1,051.38-2.58 (-0.25%) ▼|BMY62.69-0.15 (-0.24%) ▼|BNY152.26-0.76 (-0.50%) ▼|BRK-B507.55-1.65 (-0.32%) ▼|C132.20-0.50 (-0.38%) ▼|CAT800.90+2.33 (+0.29%) ▲|CL87.23-0.50 (-0.57%) ▼|CMCSA22.82-0.10 (-0.41%) ▼|COF201.54-0.50 (-0.25%) ▼|COP132.47-0.72 (-0.54%) ▼|COST894.45+0.52 (+0.06%) ▲|CRM240.74-2.11 (-0.87%) ▼|CSCO108.54-1.70 (-1.54%) ▼|CVS88.24-2.03 (-2.25%) ▼|CVX210.78-0.79 (-0.37%) ▼|DE682.13-3.51 (-0.51%) ▼|DHR211.00-1.50 (-0.71%) ▼|DIS103.30-2.06 (-1.95%) ▼|DUK117.30-1.24 (-1.05%) ▼|EMR148.62+1.22 (+0.83%) ▲|FDX303.30-2.58 (-0.84%) ▼|GD350.17-5.78 (-1.62%) ▼|GE311.75-1.72 (-0.55%) ▼|GEV929.71+4.78 (+0.52%) ▲|GILD150.25-0.65 (-0.43%) ▼|GM82.23-4.39 (-5.07%) ▼|GOOG345.96+2.28 (+0.66%) ▲|GOOGL349.95+2.62 (+0.75%) ▲|GS942.40-9.07 (-0.95%) ▼|HD300.88-1.63 (-0.54%) ▼|HON204.94-1.56 (-0.75%) ▼|IBM231.23-6.53 (-2.74%) ▼|INTC106.85-1.95 (-1.79%) ▼|INTU306.38-6.75 (-2.16%) ▼|ISRG393.48+9.94 (+2.59%) ▲|JNJ269.20-1.02 (-0.38%) ▼|JPM346.75-2.56 (-0.73%) ▼|KO87.90-0.16 (-0.19%) ▼|LIN457.91-0.57 (-0.12%) ▼|LLY1,146.04-6.40 (-0.56%) ▼|LMT527.63-10.46 (-1.94%) ▼|LOW193.08-1.11 (-0.57%) ▼|LRCX283.55+14.24 (+5.29%) ▲|MA566.52+0.79 (+0.14%) ▲|MCD250.02+1.54 (+0.62%) ▲|MDLZ60.95-1.09 (-1.76%) ▼|MDT92.67-0.11 (-0.11%) ▼|META672.85-9.47 (-1.39%) ▼|MMM164.38-0.33 (-0.20%) ▼|MO69.76+0.06 (+0.08%) ▲|MRK146.31-0.84 (-0.57%) ▼|MS202.25-1.27 (-0.62%) ▼|MSFT494.23-3.52 (-0.71%) ▼|MU990.10+12.60 (+1.29%) ▲|NEE80.54-0.74 (-0.91%) ▼|NFLX71.73-3.58 (-4.75%) ▼|NKE36.01-0.35 (-0.96%) ▼|NOW136.81-1.66 (-1.20%) ▼|NVDA219.68+0.34 (+0.16%) ▲|ORCL145.71-4.88 (-3.24%) ▼|PEP130.11-3.55 (-2.66%) ▼|PFE27.47-0.17 (-0.62%) ▼|PG146.09-1.47 (-0.99%) ▼|PLTR175.81-0.44 (-0.25%) ▼|PM190.39-0.09 (-0.05%) ▼|QCOM179.38-9.33 (-4.94%) ▼|RTX191.45-2.09 (-1.08%) ▼|SBUX95.91-0.76 (-0.79%) ▼|SCHW104.82+0.19 (+0.18%) ▲|SO85.63-1.13 (-1.30%) ▼|SPG204.29-0.18 (-0.09%) ▼|T25.52+0.13 (+0.51%) ▲|TMO652.52-5.81 (-0.88%) ▼|TMUS166.70+0.25 (+0.15%) ▲|TSLA362.20-4.01 (-1.09%) ▼|TXN263.77+5.63 (+2.18%) ▲|UBER70.28-0.59 (-0.83%) ▼|UNH373.91-1.31 (-0.35%) ▼|UNP278.87-3.61 (-1.28%) ▼|UPS99.09-1.08 (-1.08%) ▼|USB59.80-0.45 (-0.75%) ▼|V369.45-0.48 (-0.13%) ▼|VZ47.98-0.35 (-0.72%) ▼|WFC86.06-0.83 (-0.96%) ▼|WMT107.26+0.47 (+0.44%) ▲|XOM162.89-0.38 (-0.23%) ▼|
24.8 C
New York
Friday, September 18, 2026

Tag: 6

Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Increase in June 2025 of 0.6% Compared to 2024

GUADALAJARA, Mexico, July 03, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger traffic figures for June 2025, compared with June 2024.

Demo Copy now available on desktop — Start copying Lead Traders in a simulated trading environment

WOO X, a leading global crypto trading platform, is thrilled to announce that Demo Copy, a cornerstone feature of our social trading product, is now live.

Aura Minerals Announces Filing of Early Warning Report Regarding Altamira Gold Corp.

ROAD TOWN, British Virgin Islands, July 3, 2025 /CNW/ - Aura Minerals Inc. (TSX: ORA) (B3: AURA33) and (OTCQX: ORAAF) ("Aura" or the "Company") announced...

Remote Pharmacy Releases 2025 Availability Update on GLP-1 Weight Loss Solutions and Consumer Interest in Semaglutide & Tirzepatide

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.

Notification for the purposes of article 13 of the Luxembourg law of 11 January 2008 on transparency requirements for issuers    

Luxembourg (July 3, 2025) – Alvotech S.A. announces that on June 25, 2025, the proportion of own shares held by Alvotech S.A. reached 6.73%, crossing above the 5% threshold of the total number of voting rights. The above percentage has been calculated on the basis of 22,484,087 own shares out of 334,038,147 shares in issue to which voting rights are attached.

NeuroEnergizer 2025 Update Positions OTC Audio Program at Forefront of Cognitive Wellness Movement

Binaural beat-based audio suite supports focus, rest, and digital clarity with a non-invasive, non-clinical format—now updated for 2025.
Binaural beat-based audio suite supports focus, rest, and digital clarity with a non-invasive, non-clinical format—now updated for 2025.

High-Potency OTC NMN Supplement from Wonderfeel Launches Amid Surging Demand for Clean NAD+ Support Solutions

Wonderfeel’s 2025 Youngr™ update features a 900mg stabilized NMN dose with antioxidant co-factors, formulated to align with consumer interest in bioavailable, non-synthetic NAD+ wellness support.
Wonderfeel’s 2025 Youngr™ update features a 900mg stabilized NMN dose with antioxidant co-factors, formulated to align with consumer interest in bioavailable, non-synthetic NAD+ wellness support.

BUTLER NATIONAL CORPORATION ANNOUNCES FISCAL YEAR END 2025 FINANCIAL RESULTS

-Record earnings increasing to $0.19 per share -Record operating income of $16.8 million, reflecting a 27% increase from prior year OLATHE, Kan., July 3, 2025 /PRNewswire/...

Neuro Balance Therapy Update: Strongest Non-Clinical Reflex Routine for Seniors Concerned About Instability

New 2025 At-Home Protocol Uses OTC Nerve Activation Tool to Reinforce Stability, Restore Confidence, and Help Reduce Fall Risk in Adults 60+
New 2025 At-Home Protocol Uses OTC Nerve Activation Tool to Reinforce Stability, Restore Confidence, and Help Reduce Fall Risk in Adults 60+

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

Gluco6 Recognized for Strong Ingredient Transparency and OTC GLUT-4 Nutritional Support

Featuring Sukre™ for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness
Featuring Sukre™ for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness

BLUE & CO., LLC PROVIDES NOTICE OF DATA EVENT

CARMEL, Ind., July 3, 2025 /PRNewswire/ -- Blue & Co., LLC ("Blue") is a financial consultant for companies and is providing notice of an...

Bioma Probiotics Redefines Digestive Health in 2025 With Its Strongest Prebiotic, Probiotic, and Postbiotic Synergy Yet

Bioma’s transparency-driven formula highlights XOS prebiotics, targeted Bifidobacterium strains, and tributyrin postbiotics—meeting rising consumer demand for non-synthetic gut health support without promotional claims.
Bioma’s transparency-driven formula highlights XOS prebiotics, targeted Bifidobacterium strains, and tributyrin postbiotics—meeting rising consumer demand for non-synthetic gut health support without promotional claims.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags6